In situ cryo-ET visualization of mitochondrial depolarization and mitophagic engulfment
Contributors
Researchers:
Supervisors:
Description
Defective mitochondrial quality control in response to loss of mitochondrial membrane polarization is implicated in Parkinson’s disease by mutations in PINK1 and PRKN. Application of in situ cryo-electron tomography (cryo-ET) made it possible to visualize the consequences of mitochondrial depolarization at higher resolution than heretofore attainable. Parkin-expressing U2OS cells were treated with the depolarizing agents oligomycin and antimycin A (OA), subjected to cryo-FIB milling, and mitochondrial structure was characterized by in situ cryo-ET. Phagophores were visualized in association with mitochondrial fragments. Bridge-like lipid transporter (BLTP) densities potentially corresponding to ATG2A were seen connected to mitophagic phagophores. Mitochondria in OA-treated cells were fragmented and devoid of matrix calcium phosphate crystals. The intermembrane gap of cristae was narrowed and the intermembrane volume reduced, and some fragments were devoid of cristae. A subpopulation of ATP synthases re-localized from cristae to the inner boundary membrane (IBM) apposed to the outer membrane (OMM). The structure of the dome-shaped prohibitin complex, a dodecamer of PHB1-PHB2 dimers, was determined in situ by sub-tomogram averaging in untreated and treated cells and found to exist in open and closed conformations, with the closed conformation is enriched by OA treatment. These findings provide a set of native snapshots of the manifold nano-structural consequences of mitochondrial depolarization and provide a baseline for future in situ dissection of Parkin-dependent mitophagy.
Files
Airyscan image replicates.zip
Files
(587.0 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:f3c4efe7bd1c709bbc24e6839c65d76d
|
318.5 MB | Preview Download |
|
md5:c400350a8834d71bdd5cf628d3bdf4e2
|
159.6 MB | Preview Download |
|
md5:49e52a1408b8e8b26c4f51a6fb6c136f
|
10.2 kB | Preview Download |
|
md5:77e1b2b17936ef9a47e7ffa7c9610dbc
|
17.4 kB | Download |
|
md5:ef5b6e868158f737ae2c395ec0dac293
|
102.2 MB | Preview Download |
|
md5:2d549afce27e140a83d6e01597064ff2
|
1.2 kB | Preview Download |
|
md5:635c8c592c353882e8868de9b20a873f
|
23.9 kB | Download |
|
md5:fb583242730b3a960b8ba202867ef099
|
107.8 kB | Preview Download |
|
md5:eb874ed4c1de59e27d9064ce7f147b80
|
1.7 MB | Preview Download |
|
md5:1e845bfb5e9c207ab765d0afde1aae2f
|
4.9 MB | Download |
Additional details
Funding
- Aligning Science Across Parkinson's